December 5 (SeeNews) - Bulgarian drug maker Sopharma [BUL:3JR] said on Thursday that its sales revenue rose by an annual 8% in the January-November period of 2019, due to higher sales on foreign markets.
Sopharma's domestic sales fell 1% year-on-year in the first eleven months of 2019, while sales abroad grew 14%, the company said in a bourse filing.
In November alone, the company's sales jumped 24%. Exports were 27% higher on the year, while domestic sales grew 21%.
The company did not disclose information about the volume of its sales or amount of sales revenue.
As at 12:40 CET on Thursday, Sopharma shares traded at 3.45 levs ($1.96/1.76 euro), unchanged from their previous closing price on the Bulgarian Stock Exchange.
(1 euro = 1.95583 levs)